|
CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW / CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW CONTENTS 1. Clinical Trials 3. Phase 3 2. Phase 1 WH¡¦ |
|
·¹Æ÷Æ® >
±âŸ  | 
9p age   | 
1,000 ¿ø
|
|
|
|
|
|
Clinical Trials / Clinical Trials ¥°.About Clinical Trial. 1. Definition of clinical trials Although there are many definitions of clinical trials, they are generally considered to be biomedical or health-related research studies in human beings that follow a pre-defined protocol. Observational studies are those in which individuals are observed and their ¡¦ |
|
·¹Æ÷Æ® >
±âŸ  | 
6p age   | 
1,000 ¿ø
|
|
|
|
|
|
1. ÀÏ¹Ý Á¤º¸ Á¤»ó ÁúºÐ¸¸(NSVD, Normal Spontaneous Vaginal Delivery)Àº Àüü ºÐ¸¸ÀÇ ¾à 70~80%¸¦ Â÷Áö.. / 1. ÀÏ¹Ý Á¤º¸ 2. »ê¸ð·Â 3. ÇöÀç »ê°ú·Â 4. ½Å»ý¾Æ Á¤º¸ 5. ±âŸ 6. ºÐ¸¸Àå °£È£±â·ÏÁö 7. Clinical pathway 8. »ê¸ð¿¡°Ô Åõ¿©µÈ ¾à / 1. ÀÏ¹Ý Á¤º¸ Á¤»ó ÁúºÐ¸¸(NSVD, Normal Spontaneous Vaginal Delivery)Àº Àüü ºÐ¸¸ÀÇ ¾à 70~80%¸¦ Â÷ÁöÇÏ´Â ÈçÇÑ ºÐ¸¸ ¹æ¹ýÀ¸¡¦ |
|
|
|
|
|
1. Station A+Clinical Performance ExaminationÀÇ ` Station`¿¡ ´ëÇÑ ³»¿ëÀº Áß¿äÇÏ´Ù. Station.. / 1. Station 2. Guideline for Observer 3. ½Ã³ª¸®¿À / 1. Station A+Clinical Performance ExaminationÀÇ ` Station`¿¡ ´ëÇÑ ³»¿ëÀº Áß¿äÇÏ´Ù. StationÀº ÀÇÇÐ ±³À°¿¡¼ ÇлýµéÀÌ Æ¯Á¤ ÀÓ»ó ±â¼úÀ̳ª »óȲÀ» Æò°¡¹Þ´Â Æ÷ÀÎÆ®¸¦ ÀǹÌÇÑ´Ù. º¸Åë ¿©·¯ °³ÀÇ ½ºÅ×À̼ÇÀÌ ¼³Á¤µÇ¾î ÀÖ¡¦ |
|
|
|
|
|
1. ÈíÀÔÁ¤½Å ¾ÈÁ¤¹ý 2. Contraindicaton. FileSize : 29K / 1. ÈíÀÔÁ¤½Å ¾ÈÁ¤¹ý 2. Contraindicaton. / ÈíÀÔ Á¤½Å ¾ÈÁ¤¹ýÀº ¾àÁ¦ÀÇ Åõ¿© ¹æ¹ýÀÌ ¾ÆÁÖ Æí¸®ÇÑ ¹æ¹ýÀ¸·Î ÀÌ ÈíÀÔ °æ·Î·Î Åõ¿©µÇ´Â ¾àÁ¦´Â ¹ßÇö ½Ã°£, ȸº¹ ½Ã°£ÀÌ ¾ÆÁÖ ½Å¼ÓÇÏ´Ù. À̵éÀº È¿°ú´Â ½Å¼ÓÈ÷ °¡¿ªÈµÉ ¼ö ÀÖ´Ù, Åõ¿© ¾àÁ¦ÀÇ ³óµµ¸¦ ³·Ã߰ųª ²÷°í ½Ç³» °ø±â³ª »ê¼Ò¸¦ Åõ¿©ÇÔÀ¸·Î½á ¾àÈ¿´Â ½Å¼ÓÈ÷ °í°¥µÈ´Ù¡¦ |
|
|
|
|
|
»ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) »ç·Ê II: ¿ì³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö (Right-Hemisphere Dysfunction) FileSize : 35K / »ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) »ç·Ê II: ¿ì³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö (Right-Hemisphere Dysfunction) / Ãâ»ýºÎÅÍ µÎ³úÀÇ ÇÑ ÂÊ Ãø¸é¿¡ ÀÌ»óÀÌ ÀÖ¾ú´ø µÎ »ç·Ê¸¦ ÅëÇؼ ½Å°æ½É¸®ÀûÀÎ »óÅ°¡ Á¤½ÅÀû¡¦ |
|
|
|
|
|
ClinicalApplicationofBioactiveGlassGranules[1]... / ABSTRACT INTRODUCTION Results & Discussion / Results & Discussion Narrow size rangeÀÇ bioactive glass particleÀ» ´Ù·ç´Â °ÍÀº »ðÀÔµµÁß¿¡´Â ½±´Ù. HA particle°ú´Â ¹Ý´ë·Î Ç÷¾×¿¡ Á¢Ã˽à ÀÀÁý¼º ÀÖ´Â µ¢¾î¸®¸¦ Çü¼ºÇϸç Ç÷¾×¿¡ ¶° ´Ù´Ï´Â °æÇâÀ» º¸ÀÌÁö ¾Ê´Â´Ù. Áï °á¼ÕºÎÀ§¿¡ ½±°Ô ¸Å½ÄµÇ¾îÁø´Ù. ÇÑ ¹ø ¸Å½ÄµÈ particleÀº¡¦ |
|
|
|
|
|
ÀÓ»ó½É¸®¿Í °ü·ÃµÈ ·ÎÀú½ºÀÇ ÀϺ»ÁÖÀÇ ÀÚ±âÀ̷аú ÇнÀ ¹× ÇൿÀ̷п¡ ´ëÇؼ Á¶»çÇÏ¿´½À´Ï´Ù. ÀÓ»ó½É¸® / I. Á¤»ó°ú ºñÁ¤»ó II. Â÷¿ø (dimension) Áúȯ.Áõ»ó III. Roger`sÀκ»ÁÖÀÇÀÇ ÀÚ±â ÀÌ·Ð IV ÇнÀ ¹× ÇൿÀÌ·Ð / I. Á¤»ó°ú ºñÁ¤»ó 1. ¹ý·üÀû Á¤ÀÇ insame ¨çÀ§ÇèÇÏ´Ù ¨è¹«´É·ÂÇÏ´Ù 2. ¹®ÈÀû Á¤ÀÇ(Ç¥ÁرâÁØ-°¢³ª¶ó) 3. Åë°èÀû Á¤ÀÇ 4. ÁÖ°üÀû ÆÇ´Ü (personal) 5. Á¾ÇÕÀû, Àü¹®¡¦ |
|
|
|
|
|
º» ÀÚ·á´Â Clinical microbiology¿¡ ´ëÇØ Á¤¸®ÇÏ¿´½À´Ï´Ù. Clinicalmicrobiology / -¹Ì»ý¹° ÀÚµ¿È±â±â ¹× °¢Á¾ µ¿Á¤ KIT 1) ÀüÀÚµ¿ Ç÷¾×¹è¾çÀåÄ¡ 2) Ç×»ó¼º±Õ ÀÚµ¿È ¹è¾ç±â 3) ¹Ì»ý¹° ÀÚµ¿È °Ë»çÀåÄ¡ 4) µ¿Á¤ kitÀÇ »ç¿ë¹ý°ú ÁÖÀÇÁ¡ -À¯ÀüÀÚ¸¦ ÀÌ¿ëÇÏ´Â °Ë»ç¹ý 1. À¯ÀüÀÚ°Ë»çÀÇ ¸ñÀû 2. À¯ÀüÀÚ°Ë»çÀÇ ¹æ¹ý / ¡ß¹Ì»ý¹° ÀÚµ¿È±â±â ¹× °¢Á¾ µ¿Á¤ KIT¡ß 1) ÀüÀÚµ¿ Ç÷¾×¹è¾çÀåÄ¡ ÀÓ»ó°Ë¡¦ |
|
|
|
|
|
ÇнÀÀå¾Ö¿¡ °üÇÑ µÎ°¡Áö ÀÓ»ó »ç·Ê¸¦ ¼Ò°³ÇÔ ÇнÀÀå¾Ö¿¡°üÇѵΰ¡ÁöÀÓ»ó»ç·Ê / »ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) »ç·Ê II: ¿ì³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö (Right-Hemisphere Dysfunction) / »ç·Ê I: Á³ú ¹Ý±¸ÀÇ ±â´É Àå¾Ö(Left-Hemisphere Dysfunction) SamÀº Çб³¿¡¼ÀÇ Çо÷Àû ¼öÇà·ÂÀÌ ÀúÁ¶ÇÏ°í °£Áú ¹ßÀÛº´·ÂÀ¸·Î ÀÎÇØ 12¼¼ ¶§ ½É°æ½É¸®ÇÐÀû °Ë»ç¸¦ ÀÇ·ÚÇÏ¿´¡¦ |
|
·¹Æ÷Æ® >
±âŸ  | 
4p age   | 
1,000 ¿ø
|
|
|
|
|